Search Results for "FHE74110"

What is the difference between transient and stable monoclonal antibody production?

Monoclonal antibodies can be produced in mammalian systems using either transient or stable expression approaches. These two approaches have well-known advantages and limitations and each remains useful for different purposes and applications. In this article, we discuss the main differences between transient and stable monoclonal antibody production and… Read More

ProteoGenix Receives European Funding to Develop a Therapeutic Antibody for the Treatment of Inflammatory Rheumatic Diseases

ProteoGenix Receives European Funding to Develop a Therapeutic Antibody for the Treatment of Inflammatory Rheumatic Diseases April 12, 2021 In a project coordinated by ImmunOs Therapeutics AG and in partnership with Amsterdam UMC, ProteoGenix prepares to tackle an unmet medical need and alleviate the burden… Read More

ProteoGenix Launches New Human and Rabbit Antibody Libraries to Speed Up the Discovery of Better Therapeutic and Analytical Antibodies

ProteoGenix Launches New Human and Rabbit Antibody Libraries to Speed Up the Discovery of Better Therapeutic and Analytical Antibodies October 29, 2019 Schiltigheim, France – For researchers looking to accelerate the development of new immunotechnologies, ProteoGenix has created 2 new naïve rabbit and human antibody… Read More

Assistant(e) Recherche & Développement

Type d’offre : Emploi à temps plein Vous rejoignez une société de biotechnologie créée en 2003 dont le chiffre d’affaires affiche une croissance moyenne de 20 à 50% par an. ProteoGenix commercialise des produits et services dans le domaine des biotechnologies à… Read More

Assistant(e) Recherche & Développement

  Type d’offre : Stage Vous rejoignez une société de biotechnologie créée en 2003 dont le chiffre d’affaires affiche une croissance moyenne de 20 à 50% par an. ProteoGenix commercialise des produits et services dans le domaine des biotechnologies à destination de laboratoires de… Read More

ProteoGenix Boosts the Discovery of Next-Generation Biotherapeutics and Diagnostic Tools

ProteoGenix Boosts the Discovery of Next-Generation Biotherapeutics and Diagnostic Tools June 20, 2020 Schiltigheim, France – ProteoGenix today introduced a new single-domain naïve camelid antibody library (LiAb-VHHMAXTM) designed to accelerate the development of next-generation VHH antibodies for therapy and diagnostics. “VHH… Read More

What are the main cell lines used for the stable production of monoclonal antibodies?

The stable production of antibodies, particularly therapeutic monoclonal antibodies, has long been dominated by mammalian recombinant systems. Despite their complex genetic background, cell lines like Chinese hamster ovary (CHO) and murine myeloma cells, are very amenable to growth in suspension in serum-free medium and highly tolerant to changes… Read More

Checkout

Read More

Gene Synthesis

Read More

Bioreagents for Therapeutic Research

Read More